AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Bevacizumab in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Avastin 100 mg** Concentrate for solution for infusion | A6-0123 | Roche Products Limited | active | 22 Feb 2028 |
| Avastin 400 mg/16 mL Concentrate for solution for infusion | A6-0101 | — | active | — |
Bevacizumab — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Bevacizumab, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Bevacizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.